Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAINtenance of remission with rituximab versus azathioprine in EGPA
2016-000627-53Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in eosinophilic granulomatosis with polyangiitis (EGPA) comparing Rituximab maintenance with Azathioprine maintenance (2 arms). Primary endpoint: Primary assessment criterion. Started Jun 2018; status: completed.
02
Drugs
rituximabazathioprine
03
Conditions
eosinophilic granulomatosis with polyangiitis (EGPA)
Beyond the preview
Go deeper on 2016-000627-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000627-53.